Literature DB >> 33184959

Chronic kidney disease is a very significant comorbidity for high risk of death in patients with COVID-19 in Mexico.

Gaspar Manuel Parra-Bracamonte1, Francisco E Parra-Bracamonte2, Nicolas Lopez-Villalobos3, Ana Laura Lara-Rivera4.   

Abstract

Chronic kidney disease (CKD) is a recognized public health problem and key determinant of poor health outcomes. In Mexico, this condition has been associated with high and significant risk of death in COVID-19 patients; however, not enough attention has been given to the vulnerable population as the increasing numbers and fatality rates suggest. This study evaluated the effect of interaction between CKD condition and other risk factors (sex, diabetes, hypertension and obesity) on the survival rate of positive patients for COVID-19 in Mexico. The results from this study support that CKD patients is a population at high risk for mortality for COVID-19 and that COVID-19 positive inpatients with CKD and diabetes are highly vulnerable to death.
© 2020 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  CKD; coronavirus; fatality; survival

Year:  2020        PMID: 33184959     DOI: 10.1111/nep.13827

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  7 in total

1.  Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study.

Authors:  J M Vera-Zertuche; J Mancilla-Galindo; M Tlalpa-Prisco; P Aguilar-Alonso; M M Aguirre-García; O Segura-Badilla; M Lazcano-Hernández; H I Rocha-González; A R Navarro-Cruz; A Kammar-García; J de J Vidal-Mayo
Journal:  Epidemiol Infect       Date:  2021-04-29       Impact factor: 2.451

Review 2.  COVID-19 and chronic kidney disease: an updated overview of reviews.

Authors:  Sara S Jdiaa; Razan Mansour; Abdallah El Alayli; Archana Gautam; Preston Thomas; Reem A Mustafa
Journal:  J Nephrol       Date:  2022-01-11       Impact factor: 3.902

Review 3.  The Impact of COVID-19 on Patients With ADPKD.

Authors:  Meherzad Kutky; Erin Cross; Darin J Treleaven; Ahsan Alam; Matthew B Lanktree
Journal:  Can J Kidney Health Dis       Date:  2021-11-10

4.  Challenges for Peritoneal Dialysis Centers Before and During the COVID-19 Pandemic in Mexico.

Authors:  Diana Perez-Moran; Ricardo Perez-Cuevas; Svetlana V Doubova
Journal:  Arch Med Res       Date:  2022-04-29       Impact factor: 8.323

5.  Diabetes and Mortality among Patients with Chronic Kidney Disease and COVID-19: A Systematic Review, Meta-analysis, and Meta-regression.

Authors:  Maria R Iryaningrum; Rudi Supriyadi; Sherly Lawrensia; Joshua Henrina; Nanny Natalia M Soetedjo
Journal:  Indian J Nephrol       Date:  2022-05-20

6.  Association between chronic kidney disease and mortality in patients with a confirmed COVID-19 diagnosis.

Authors:  Jacqueline Betsabe Puicón-Suárez; Sandra Zeña-Ñañez; Virgilio E Failoc-Rojas
Journal:  PeerJ       Date:  2022-06-14       Impact factor: 3.061

7.  Association of underlying comorbidities and progression of COVID-19 infection amongst 2586 patients hospitalised in the National Capital Region of India: a retrospective cohort study.

Authors:  Rashmi Rana; Vivek Ranjan; Naveen Kumar; Parul Chugh; Kamini Khillan; Atul Gogia; Devinder Singh Rana; Nirmal Kumar Ganguly
Journal:  Mol Cell Biochem       Date:  2022-06-25       Impact factor: 3.842

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.